LEKTI; LETKI; NETS; NS; VAKTI; Lymphoepithelial Kazal-Type-Related Inhibitor; Lympho-epithelial Kazal-type-related inhibitor
CD29; MSK12; ITG-B1; FNRB; GPIIA; MDF2; MSK12; VLAB; Fibronectin Receptor Beta Polypeptide; Antigen CD29 Includes MDF2; Glycoprotein IIa; VLA-4 subunit beta
COL6-A1; OPLL; Collagen Alpha-1(VI)chain
CD29; MSK12; ITG-B1; FNRB; GPIIA; MDF2; MSK12; VLAB; Fibronectin Receptor Beta Polypeptide; Antigen CD29 Includes MDF2; Glycoprotein IIa; VLA-4 subunit beta
GSHPX1; Cellular glutathione peroxidase
PCTT; PSTI; TATI; Tumor-Associated Trypsin Inhibitor; Pancreatic secretory trypsin inhibitor; Tumor-associated trypsin inhibitor
CD51; ITG-AV; MSK8; VNRA; Vitronectin Receptor,Alpha Polypeptide
GSHPX1; Cellular glutathione peroxidase
ITGaM; ITG-AM; CR3A; MAC-1; MAC1A; MO1A; Complement Component 3 Receptor 3 Subunit; Cell surface glycoprotein MAC-1 subunit alpha; Neutrophil adherence receptor
COL6-A1; OPLL; Collagen Alpha-1(VI)chain
GSHPX1; Cellular glutathione peroxidase
PZI; ZPI; Serine(Cysteine)Proteinase Inhibitor,Clade A(Alpha-1 Antiproteinase,Antitrypsin)Member 10; Protein Z-Related Protease Inhibitor; Protein Z Dependent Protease Inhibitor